Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection

Summary

This is a prospective, double-blind, randomized, placebo-controlled study in two distinct cohorts to evaluate the efficacy and safety of hydroxychloroquine in the prevention of COVID-19 infection.

Timeline

Start

2020-05-14

Primary completion

2021-06-04

Completion

2021-06-04

Drugs

Indications